Insulin resistance and impaired adipogenesis

Trends in Endocrinology and Metabolism

Volumn 26, Issue 4, 2015, Pages 193-200

  Gustafson, Birgit ^a   Hedjazifar, Shahram ^a   Gogg, Silvia ^a   Hammarstedt, Ann ^a   Smith, Ulf ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adipogenesis; BMP4; Gremlin1; Insulin resistance; Obesity; Type 2 diabetes

Indexed keywords

BONE MORPHOGENETIC PROTEIN; GLUCOSE TRANSPORTER 4; LIPID; SLC2A4 PROTEIN, HUMAN;

ADIPOGENESIS; ADIPOSE TISSUE; ADIPOSE TISSUE CELL; CELL DIFFERENTIATION; CELL SIZE; EPIDEMIC; GLUCOSE TRANSPORT; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIPOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK; SUBCUTANEOUS FAT; WHITE ADIPOCYTE; ABDOMINAL SUBCUTANEOUS FAT; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; BROWN ADIPOSE TISSUE; DOWN REGULATION; GENETICS; HYPERTROPHY; IMMUNOLOGY; LIPID METABOLISM; METABOLIC SYNDROME X; METABOLISM; OBESITY; PATHOLOGY;

ADIPOGENESIS; ADIPOSE TISSUE, BROWN; ADIPOSITY; ANIMALS; DOWN-REGULATION; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPERTROPHY; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 84933673558     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.01.006     Document Type: Review

References (80)

1. Xu Y., et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013, 310:948-959.
2. Kloting N., et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E506-E515.
3. Twig G., et al. Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care 2014, 37:2989-2995.
4. Scott R.A., et al. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independently of obesity. Diabetes 2014, 63:4378-4387.
5. Fox K.A., et al. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur. Heart J. 2009, 30:3055-3063.
6. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
7. Virtue S., Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome - an allostatic perspective. Biochim. Biophys. Acta 2010, 1801:338-349.
8. Kim J.Y., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 2007, 117:2621-2637.
9. Reitman M.L., et al. Lipoatrophy revisited. Trends Endocrinol. Metab. 2000, 11:410-416.
10. Kim S.M., et al. Loss of white adipose hyperplastic potential is associated with enhanced susceptibility to insulin resistance. Cell Metab. 2014, 20:1049-1058.
11. Spalding K.L., et al. Dynamics of fat cell turnover in humans. Nature 2008, 453:783-787.
12. Tchoukalova Y.D., et al. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18226-18231.
13. Kadowaki T., et al. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int. J. Obes. (Lond.) 2006, 30:1163-1165.
14. Graner M., et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J. Clin. Endocrinol. Metab. 2013, 98:1189-1197.
15. Boren J., et al. Ectopic lipid storage and insulin resistance: a harmful relationship. J. Intern. Med. 2013, 274:25-40.
16. Neeland I.J., et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012, 308:1150-1159.
17. Krotkiewski M., et al. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest. 1983, 72:1150-1162.
18. Arner E., et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010, 59:105-109.
19. Gustafson B., et al. Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E999-E1003.
20. Weyer C., et al. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000, 43:1498-1506.
21. Arner P., et al. Genetic predisposition for type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS ONE 2011, 6:e18284.
22. InterAct Consortium, et al. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med. 2012, 9:e1001230.
23. Cederberg H., et al. Family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage?. J. Intern. Med. 2014, Published online July 12, 2014. http://dx.doi.org/10.1111/joim.12289.
24. Isakson P., et al. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-α, and inflammation. Diabetes 2009, 58:1550-1557.
25. Majithia A.R., et al. Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:13127-13132.
26. Virtanen K.A., et al. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J. Clin. Endocrinol. Metab. 2002, 87:3902-3910.
27. Abel E.D., et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001, 409:729-733.
28. Herman M.A., et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 2012, 484:333-338.
29. Graham T.E., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 2006, 354:2552-2563.
30. Norseen J., et al. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and Toll-like receptor 4-dependent and retinol-independent mechanism. Mol. Cell. Biol. 2012, 32:2010-2019.
31. Yore M.M., et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 2014, 159:318-332.
32. Carvalho E., et al. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J. 2001, 15:1101-1103.
33. Smith U. Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance - is insulin resistance initiated in the adipose tissue?. Int. J. Obes. Relat. Metab. Disord. 2002, 26:897-904.
34. Addison W.N., et al. Direct transcriptional repression of Zfp423 by Zfp521 mediates a bone morphogenic protein-dependent osteoblast versus adipocyte lineage commitment switch. Mol. Cell. Biol. 2014, 34:3076-3085.
35. Gao H., et al. Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue. Cell Metab. 2014, 19:981-992.
36. Gustafson B., et al. BMP4 and BMP antagonists regulate human white and beige adipogenesis. Diabetes 2015, Published online January 20, 2015. http://dx.doi.org/10.2337/db14-1127.
37. Elsen M., et al. BMP4 and BMP7 induce the white-to-brown transition of primary human adipose stem cells. Am. J. Physiol. Cell Physiol. 2014, 306:C431-C440.
38. Hammarstedt A., et al. WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:2563-2568.
39. Gupta R.K., et al. Transcriptional control of preadipocyte determination by Zfp423. Nature 2010, 464:619-623.
40. Gustafson B., Smith U. The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 2012, 61:1217-1224.
41. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 2006, 7:885-896.
42. Rosen E.D., Spiegelman B.M. What we talk about when we talk about fat. Cell 2014, 156:20-44.
43. Bowers R.R., et al. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:13022-13027.
44. Tseng Y.H., et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008, 454:1000-1004.
45. Felin J.E., et al. Nuclear variants of bone morphogenetic proteins. BMC Cell Biol. 2010, 11:20.
46. Topol L.Z., et al. Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin. J. Biol. Chem. 2000, 275:8785-8793.
47. Costello C.M., et al. Role of Gremlin in the lung: development and disease. Am. J. Respir. Cell Mol. Biol. 2010, 42:517-523.
48. Virtanen K.A., et al. Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 2009, 360:1518-1525.
49. Cypess A.M., et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 2009, 360:1509-1517.
50. van Marken Lichtenbelt W.D., et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 2009, 360:1500-1508.
51. Zingaretti M.C., et al. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J. 2009, 23:3113-3120.
52. Jespersen N.Z., et al. A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab. 2013, 17:798-805.
53. Orava J., et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 2011, 14:272-279.
54. Ouellet V., et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J. Clin. Invest. 2012, 122:545-552.
55. Chondronikola M., et al. Brown adipose tissue improves whole body glucose homeostasis and insulin sensitivity in humans. Diabetes 2014, 63:4089-4099.
56. Sharp L.Z., et al. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS ONE 2012, 7:e49452.
57. Wu J., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012, 150:366-376.
58. Kajimura S., et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-β transcriptional complex. Nature 2009, 460:1154-1158.
59. Long J.Z., et al. A smooth muscle-like origin for beige adipocytes. Cell Metab. 2014, 19:810-820.
60. Rosenwald M., Wolfrum C. The origin and definition of brite versus white and classical brown adipocytes. Adipocyte 2014, 3:4-9.
61. Schulz T.J., et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:143-148.
62. Andersson C.X., et al. Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes Metab. Res. Rev. 2008, 24:595-603.
63. Richardson V.R., et al. Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus. Immunobiology 2013, 218:1497-1504.
64. Weisberg S.P., et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
65. Xu H., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.
66. Bruun J.M., et al. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E961-E967.
67. Cancello R., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286.
68. Kanda H., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116:1494-1505.
69. Mine S., et al. Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem. Biophys. Res. Commun. 2006, 344:780-785.
70. Lumeng C.N., et al. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117:175-184.
71. Hotamisligil G.S., et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 1996, 271:665-668.
72. Wernstedt Asterholm I., et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 2014, 20:103-118.
73. Gordon S. Macrophage heterogeneity and tissue lipids. J. Clin. Invest. 2007, 117:89-93.
74. Qiu Y., et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014, 157:1292-1308.
75. Rui L., et al. Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J. Clin. Invest. 2001, 107:181-189.
76. Bouhlel M.A., et al. PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007, 6:137-143.
77. Odegaard J.I., et al. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab. 2008, 7:496-507.
78. Koppaka S., et al. Reduced adipose tissue macrophage content is associated with improved insulin sensitivity in thiazolidinedione-treated diabetic humans. Diabetes 2013, 62:1843-1854.
79. Yuan M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 2001, 293:1673-1677.
80. Goldfine A.B., et al. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin. Transl. Sci. 2008, 1:36-43.